Calcium channel blockers are first-line therapy for vasospastic angina, a condition often overlooked despite established diagnostic and therapeutic pathways.
Vasospastic angina
Calcium channel blockers
Vasospastic angina is a well-established cause of chest pain that is caused by coronary artery spasm. It can be clinically diagnosed during a spontaneous episode by documenting nitrate-responsive rest angina with associated transient ischaemic ECG changes but more often requires provocative coronary spasm testing with acetylcholine during coronary angiography. Vasospastic angina may result in recurrent episodes of angina (including nocturnal angina), which can progress on to major adverse cardiac events. Calcium channel blockers are first-line therapy for this condition, given their anti-anginal and cardioprotective benefits. Despite an established diagnostic and therapeutic management pathway for vasospastic angina, this diagnosis is often overlooked in patients presenting with chest pain. Thus, there is need for increased clinical awareness of vasospastic angina to improve outcomes in affected patients.
Building similarity graph...
Analyzing shared references across papers
Loading...
John F. Beltrame
General Cardiology
Heart
The University of Adelaide
Women's and Children's Health Network
Basil Hetzel Institute
Building similarity graph...
Analyzing shared references across papers
Loading...
John F. Beltrame (Fri,) conducted a review in Vasospastic angina. Calcium channel blockers was evaluated. Calcium channel blockers are first-line therapy for vasospastic angina, a condition often overlooked despite established diagnostic and therapeutic pathways.
synapsesocial.com/papers/6a2265e3f4540fbb2453d1ec — DOI: https://doi.org/10.1136/heartjnl-2022-321268
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: